Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
Logan Hamilton, Freelance Writer, shared a post on LinkedIn:
“Vaccine hesitancy often grows from misleading or conspiratorial claims.
Yet, rare vaccine side effects can still occur.
Previous research confirmed dangerous blood clots after some COVID-19 vaccinations. These clots appeared only after administration of adenovirus-based COVID-19 vaccines.
Scientists have now identified a likely cause of these symptoms, known as vaccine-induced thrombocytopenia and thrombosis (VITT). The team discovered a mutated antibody gene that causes VITT symptoms.
This gene was delivered by adenovirus COVID-19 vaccines. Results showed the mutation triggered rare but dangerous blood clotting.
VITT is extremely rare among vaccinated individuals. It occurred in about one in 200,000 recipients. Only adenovirus-based COVID-19 vaccines showed this risk. mRNA COVID-19 vaccines did not show the same pattern.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios AndreadisÖ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI